Anesthesia Pharmacology Chapter 25: Pulmonary Pharmacology Practice Questions

1 / 10

Example(s) of short-acting ß₂ agonist/agonist:
1. Levalbuterol
2. Pirbuterol
3. Metaproterenol
4. A & B
5. B & C
6. A & C
7. A, B & C
This/these drugs represent(s) an important advance in both asthma and COPD treatment:
1. Fomoterol
2. Salmeterol
3. Both
4. Neither
Which one of the following drugs is NOT categorized as a long-acting inhaled ß₂adrenergic drug agonist?
1. Terbutaline
2. Arformoterol
3. Salmeterol
Long-acting inhaled ß₂ adrenergic receptor agonists exhibit bronchodilator effects and protect against bronchoconstriction for about 12 hours.
1. True
2. False
Which one(s) of the following represent "once-daily" long-acting inhaled ß₂ adrenergic receptor agonists especially useful in treating COPD?
1. Vilanterol
2. Indacaterol
3. Olodaterol
4. A & B
5. B & C
6. A & C
7. A, B & C
Which one(s) of the following statement/statements is/are correct?
1. In comparing fomoterol and salmeterol: fomoterol exhibits more rapid onset and is classified as nearly a full agonist.
2. In comparing fomoterol in salmeterol: salmeterol shows a relatively slower onset of effect and is classified as a partial agonist.
3. Both
4. Neither
In treating COPD, long-acting ß₂ adrenergic agonists, effective bronchodilators, can be used in combination with anticholinergic drugs.
1. True
2. False
In treating asthma, long-acting ß₂-adrenergic agonists would be most appropriately used alone, in monotherapy.
1. True
2. False
Long acting ß₂ adrenergic agonists should always be used in combination with an inhaled corticosteroid (fixed-dose combination inhaler) to ensure that the underlying chronic inflammatory component of asthma is addressed.
1. True
2. False
If asthma is not adequately controlled at low inhaled corticosteroid doses, long-acting ß₂ adrenergic agonists represent an effective add-on treatment.
1. True
2. False